The Study
This is a pragmatic, randomized, multicenter, controlled trial in which participants will be randomized to a 9-month precision medicine treatment approach or a 9-month standard treatment approach. The standard treatment approach group had the option to receive up to six months of precision medicine treatment and testing at no cost following the completion of the trial.
Both groups were tested at baseline using cognitive assessments and blood testing which will be repeated throughout the study. Both groups participated in monthly appointments with a physician. The lifestyle intervention portion of this study assessed the impact of diet, exercise, stress, sleep and environment.
We evaluated people who live within 1-hour of one of our six trial sites and who fall within the age range of 45-76. You can see our full inclusion and exclusion criteria on ClinicalTrials.gov.
The results of the EVANTHEA trial have not yet undergone peer review. The intervention evaluated in the EVANTHEA trial is not approved by the U.S. Food and Drug Administration for the treatment, cure, or prevention of Alzheimer’s disease, mild cognitive impairment, or dementia. This summary is provided for scientific and informational purposes only and is not intended as medical advice.
